BackPsyence Biomedical Overview

Psyence Biomedical Long Term Debt

Latest long-term debt for PBM: $0.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$0.00

Peer trimmed avg / median

Loading

Psyence Biomedical Long Term Debt History

Loading

Psyence Biomedical vs. peers: Long Term Debt Comparison

Loading

Psyence Biomedical Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Psyence Biomedical (PBM) FAQ

As of the most recent data (September 2025), PBM shows a long-term debt of $0. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PBM's long-term debt is now $0 (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Psyence Biomedical is outperforming or lagging.

Tracking PBM's long-term debt over time shows whether Psyence Biomedical is scaling, shrinking, or reshaping that part of the business. The current reading is $0 In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has Psyence Biomedical's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $0) with ownership activity and broader fundamentals.